V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270017108 | 270014904 | 1.77 | 69.4 | Curative (C) | 2016-12-02 | 2016-12-31 | DACARBAZINE + DOXORUBICIN + VINBLASTINE | N | N | 270022647 | BLEOMYCIN |
| 270017109 | 270010503 | null | 139.2 | Palliative (P) | 2018-05-19 | 2018-05-26 | ICE-R | N | N | 270022660 | GEMCITABINE + OXALIPLATIN |
| 270017110 | 270010506 | 1.58 | 89 | Curative (C) | 2014-04-11 | 2014-04-11 | DACARBAZINE + DOXORUBICIN + VINBLASTINE | 02 | N | 270022702 | ECHELON 1 TRIAL |
| 270017111 | 270010507 | 1.66 | 0 | Curative (C) | 2016-02-16 | 2018-10-20 | FLUDARABINE | N | N | 270022706 | BLEOMYCIN |
| 270017112 | 270010509 | 1.75 | null | Not known (9) | 2015-02-07 | 2015-02-20 | R GCVP | N | N | 270022796 | DACARBAZINE + DOXORUBICIN + VINBLASTINE |
| 270017113 | 270010510 | 1.65 | 102 | Curative (C) | 2018-06-07 | 2018-06-14 | IDELALISIB + RITUXIMAB | 02 | N | 270022812 | IBRUTINIB |
| 270017114 | 270010511 | 1.84 | 135.4 | Palliative (P) | 2014-09-20 | 2014-09-21 | Cyclophosphamide + Fludarabine IV | 02 | N | 270022820 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 270017115 | 270010512 | 1.63 | 86.55 | Palliative (P) | 2014-02-25 | 2014-03-02 | FEC 100 | 02 | N | 270022858 | GEMCARBO |
| 270017116 | 270010515 | 1.73 | 66.199 | Curative (C) | 2018-05-18 | 2018-05-18 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 270022895 | CYCLOPHOSPHAMIDE + DACARBAZINE + VINCRISTINE |
| 270017117 | 270010520 | 1.73 | 67 | Palliative (P) | 2015-01-17 | 2015-02-24 | DHAP - R | N | N | 270022944 | GDCVP |
| 270017118 | 270014915 | 1.54 | 73.2 | Curative (C) | null | 2016-10-26 | VINCRISTINE | N | N | 270022967 | IMATINIB |
| 270017119 | 270010523 | 1.54 | 61.9 | Curative (C) | 2015-06-07 | 2015-07-09 | BLEOMYCIN | N | N | 270022978 | DACARBAZINE + DOXORUBICIN + VINBLASTINE |
| 270017120 | 270010527 | 1.73 | null | Disease modification (D) | 2017-02-08 | 2017-02-15 | LACE | 2 | N | 270022987 | HYDROXYCARBAMIDE |
| 270017121 | 270014919 | 1.68 | 106 | Curative (C) | 2017-02-09 | 2017-02-09 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 270023031 | FLUDARABINE |
| 270017123 | 270019719 | 1.75 | 65 | Curative (C) | 2019-02-10 | 2019-02-18 | CARBOPLATIN + ETOPOSIDE + IFOSFAMIDE | N | N | 270023120 | DOXORUBICIN |
| 270017124 | 270019719 | 1.73 | 70 | Curative (C) | null | 2018-02-13 | DACARBAZINE + DOXORUBICIN + VINBLASTINE | 2 | N | 270023120 | METHOTREXATE INTRATHECAL |
| 270017125 | 270018541 | 1.71 | 73 | Curative (C) | 2017-12-06 | 2017-12-06 | Gemcitabine + Vinorelbine IV | 2 | N | 270023155 | ICE |
| 270017126 | 270010536 | 1.7 | 104 | Curative (C) | 2015-12-20 | 2015-12-26 | CARBOPLATIN + RT | N | N | 270023156 | CARBOPLATIN + RT |
| 270017127 | 270010538 | 1.65 | 68.1 | Curative (C) | 2015-05-30 | 2015-06-19 | Bortezomib + Cyclophos + Dex | 2 | N | 270023165 | MELPHALAN |
| 270017128 | 270010539 | 1.6 | null | Curative (C) | 2016-11-20 | 2016-12-25 | NHL 2003 Gp B COP | N | null | 270023166 | CYCLOPHOSPHAMIDE |
| 270017129 | 270010546 | 1.8 | 72.9 | Curative (C) | 2014-12-14 | 2014-12-14 | ECHELON 1 TRIAL | N | N | 270023172 | TEMOZOLOMIDE |
| 270017130 | 270017233 | null | 0 | Curative (C) | 2015-04-17 | 2015-05-11 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | N | N | 270023185 | DHAP - R |
| 270017131 | 270010548 | 1.84 | 80 | Palliative (P) | 2016-02-06 | 2016-03-01 | ICE-R | N | N | 270023195 | CISPLATIN + GEMCITABINE + RITUXIMAB |
| 270017132 | 270019294 | 1.56 | 77.6 | Palliative (P) | null | 2016-11-22 | R GCVP | 2 | N | 270023299 | ALEMTUZUMAB + CYCLO + FLUDARABINE |
| 270017133 | 270010555 | 1.79 | 93.1 | null | 2017-03-11 | 2017-03-11 | ICE + GCSF | 2 | N | 270023301 | CHLORAMBUCIL |
| 270017134 | 270017235 | 1.68 | 92.1 | Curative (C) | 2016-12-22 | 2017-01-07 | CVP R | N | N | 270023336 | DOXORUBICIN |
| 270017135 | 270010559 | 1.96 | 85 | Palliative (P) | 2016-09-13 | 2016-09-15 | Y-90 | N | N | 270023353 | DOXORUBICIN |
| 270017136 | 270010563 | 1.73 | 67.5 | Palliative (P) | 2017-08-19 | 2017-08-19 | R-PMitCEBOM | N | N | 270023365 | ETOPOSIDE |
| 270017137 | 270010566 | 1.7 | null | Palliative (P) | 2016-04-19 | 2016-11-29 | Y-90 | null | null | 270023394 | DHAP - R |
| 270017138 | 270018544 | 1.64 | 98 | Curative (C) | 2017-08-12 | 2017-08-12 | ETOPOSIDE | 01 | Y | 270023407 | TEMOZOLOMIDE |
| 270017139 | 270018544 | null | null | Palliative (P) | 2014-09-24 | 2014-12-17 | LACE | null | Y | 270023407 | ICE |
| 270017140 | 270010571 | 1.7 | 106 | Adjuvant (A) | null | 2018-05-15 | GEMCITABINE + VINORELBINE | N | N | 270023459 | CISPLATIN + GEMCITABINE + RITUXIMAB |
| 270017141 | 270017239 | 1.71 | 60.6 | Not known (9) | 2014-04-30 | 2014-05-20 | Fludarabine + Melphalan RIC Allo | 01 | N | 270023484 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 270017142 | 270010578 | 1.45 | null | Curative (C) | 2015-02-18 | 2015-02-19 | CYCLOPHOSPHAMIDE + ETOPOSIDE + Procarbazine | N | Y | 270023517 | CYCLOPHOSPHAMIDE + ETOPOSIDE + LOMUSTINE |
| 270017143 | 270010581 | null | null | Palliative (P) | 2015-11-21 | 2015-11-22 | Gemcitabine + Oxaliplatin | 02 | null | 270023542 | CHLVPP/PABLOE |
| 270017144 | 270010584 | 1.71 | null | Palliative (P) | 2016-12-26 | 2016-12-26 | ICE-R | N | N | 270023574 | CYCLOPHOSPHAMIDE |
| 270017145 | 270010586 | 1.61 | 86.55 | Not known (9) | 2014-02-03 | 2014-02-15 | CYCLOPHOSPHAMIDE + MESNA | N | N | 270023584 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 270017146 | 270010588 | 1.75 | 61 | Palliative (P) | 2015-08-03 | 2015-08-03 | CVP R | 02 | Y | 270023591 | CYTARABINE + METHOTREXATE + RITUXIMAB + THIOTEPA |
| 270017147 | 270010590 | 1.8 | 84.8 | Neo-adjuvant (N) | 2015-03-03 | 2015-04-19 | Fludarabine + Melphalan RIC Allo | N | N | 270023661 | RATHL TRIAL |
| 270017148 | 270014942 | 1.93 | 66.7 | Curative (C) | 2017-04-02 | 2017-04-26 | Hydroxycarbamide | N | N | 270023690 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 270017149 | 270010594 | 1.6 | 52.3 | Curative (C) | 2016-08-05 | 2016-10-07 | ICE | N | N | 270023702 | CVD |
| 270017150 | 270010595 | 1.88 | 83 | Palliative (P) | 2017-04-16 | 2017-05-07 | BLEOMYCIN | 02 | Y | 270023704 | DACARBAZINE + DOXORUBICIN + VINBLASTINE |
| 270017151 | 270010599 | 1.95 | null | Curative (C) | 2015-01-03 | 2015-08-11 | GEMCITABINE + OXALIPLATIN + RITUXIMAB | 02 | N | 270023805 | ICE |
| 270017152 | 270014946 | 1.83 | 79.4 | Palliative (P) | null | 2013-10-22 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 270023835 | CHLORAMBUCIL + ETOPOSIDE + LOMUSTINE |
| 270017153 | 270010603 | 1.72 | 92.4 | null | null | 2014-05-10 | ICE | N | N | 270023853 | BLEOMYCIN |
| 270017154 | 270010603 | 1.72 | 97 | Curative (C) | 2016-01-11 | 2016-01-12 | ICE | N | N | 270023853 | ECHELON 1 TRIAL |
| 270017155 | 270014948 | 1.68 | 80 | null | 2017-12-27 | 2018-01-31 | ICE | N | N | 270023880 | CVP R |
| 270017156 | 270010605 | null | 89 | Not known (9) | 2017-03-10 | 2017-05-05 | R-PMitCEBOM | N | N | 270023883 | BENDAMUSTINE + RITUXIMAB |
| 270017157 | 270014950 | 0 | 70.3 | Not known (9) | 2017-03-04 | 2017-03-04 | CISPLATIN + GEMCITABINE + RITUXIMAB | 02 | N | 270023921 | METHOTREXATE INTRATHECAL |
| 270017158 | 270014951 | 1.62 | 70.5 | Not known (9) | 2016-10-28 | 2017-08-13 | IDELALISIB | 02 | N | 270024025 | MELPHALAN |